Clinical TrialsSearch results
Number of results: 1187
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to an Alpha-Glucosidase Inhibitor
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A phase 3 confirmatory study of booster dose of VLPCOV-04 vaccine
- Prevention of infectious disease caused by SARS-CoV-2
- Masayuki Aboshi
- 2023-12-04
Recruiting
- A Phase 3 study of belrestotug plus dostarlimab compared with placebo plus pembrolizumab in previously untreated PD-L1 high NSCLC
- Non-small-cell lung cancer
- Ishibashi Hideyasu
- 2024-06-04
Completed
- A Phase 3 Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis
- Hyperphosphatemia Patients on Peritoneal Dialysis
- Kinoshita Jun
- 2021-03-04
Other
- A phase 3 study to evaluate safety of booster immunization by VLPCOV-04 vaccine
- Prevention of infectious disease caused by SARS-CoV-2
- Masayuki Aboshi
- 2024-02-07
Recruiting
- A Phase 3 Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Deucravacitinib
(BMS-986165) in Pediatric Subjects with Moderate to Severe Plaque Psoriasis
- Plaque Psoriasis
- Duculan Fuentes Judilyn
- 2022-12-26
Completed
- A Phase 3, Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis.
- Hyperphosphatemia Patients on Hemodialysis
- Kinoshita Jun
- 2021-03-04
Recruiting
- A Phase 3b,randomized,multicenter,open-label trial of Atezolizumab plus Bevacizumab versus transarterial Chemoembolization(TACE) in intermediate-stage HepatoCellular Carcinoma
- Intermediate-stage HepatoCellular Carcinoma
- Kudo Masatoshi
- 2021-11-24
Not yet recruiting
- A PHASE I STUDY OF BRY10 IN HEALTHY MALE ADULTS
- Healthy Volunteers
- Kai Megumi
- 2024-09-11
Other
- A phase I study of cancer vaccine with NY-ESO-1 overlapping peptides in patients with advanced cancers expressing NY-ESO-1 antigen
- advanced esophageal cancer, stomach cancer, non-small cell lung cancer (NSCLC), malignant melanoma, bladder cancer.
- Department of Immunology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- 2009-04-10